Bioactivity:

Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent CXCR4 antagonist and an anti-angiogenic drug that is of potential value in treating choroid neovascularization.

CAS nr:

1191450-19-7

Purity:

98%

Molecular Weight:

769,01

SMILES:

NC1=CC(N2CCN(CCP(O)(O)=O)CC2)=NC(NC[C@H]3CC[C@H](CNCCCNC4CCCCC4)CC3)=N1.[H]Br.[5/2]

Formula:

C27H51N8O3P.5/2HBr

Pathway:

Autophagy,Immunology/Inflammation,GPCR/G Protein

Target:

CXCR,CXCR,CXCR